Glioma Susceptibility 2 C2751642
A genetic susceptibility to gliomas, brain tumors arising from glial cells. Inherited gene changes increase tumor risk. Surveillance and genetic counseling are typically advised.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Headache
Seizure
Visual disturbances
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Cognitive impairment
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Enhanced Brain MRI Surveillance
Regular brain MRI scans with contrast to detect any glioma development early. Surveillance frequency based on individual risk profile and family history typically ranging from annual to twice-yearly imaging.
Cognitive Reserve Building
Engagement in mentally stimulating activities, regular exercise, and social engagement to build neural resilience. These activities may support brain health and cognitive function.
Additional treatment options
Anti-inflammatory Diet
Adoption of Mediterranean-style diet rich in omega-3 fatty acids, colorful vegetables, and whole grains. This may help reduce systemic inflammation that could contribute to tumor development.
dietaryGenetic Counseling and Support
Psychological support services including genetic counseling to help patients and families understand their risk profile, cope with anxiety, and make informed decisions about screening.
psychologicalNeuro-oncology Surgical Consultation
Preemptive consultation with neuro-oncology team to establish baseline assessment and discuss potential surgical options should a tumor be detected. Early surgical planning improves outcomes.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Glioma Susceptibility 2 C2751642?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Glioma Susceptibility 2 C2751642. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy